Gabapentin Capsule
Product Images NDC 72162-1533

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text appears to be a description of a study or experiment evaluating the effect of different doses of Gabapentin on pain scores over a period of 7 weeks. The study involved a fixed dose period of 4 weeks, with different doses of Gabapentin administered throughout. The pain scores were measured at baseline and weekly throughout the study.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label (Lbl721621533)

Label (Lbl721621533)
This is a description for Gabapentin Capsules. Each capsule contains 300 mg of gabapentin, USP. It is important to keep the medication out of reach of children and store it at a temperature between 20° to 25° C (68° to 77° F). The medication should be dispensed in a tight container with a child-resistant closure. Pharmacists should provide the patient package inserts and medication guide. The medication is manufactured by ScieGen Pharmaceuticals and relabeled by Bryant Ranch Prepack, Inc. The NDC number for this product is 72162-1533-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.